Healthcare Industry News: BVA-100
News Release - October 12, 2006
Daxor Corporation Announces Queens Medical Center of Honolulu, HI Acquires Second Blood Volume Analyzer
NEW YORK--(HSMN NewsFeed)--Daxor Corporation (AMEX:DXR ), a medical instrumentation and biotechnology company, today announced receipt of a signed trial agreement from the Queen's Medical Center in Honolulu, Hawaii for its second Blood Volume Analyzer. Queen's Medical Center, which purchased its first BVA-100 following a trial agreement, utilized blood volume measurements for various clinical applications. This second BVA-100 will be utilized specifically for treating blood volume derangements in the critical care unit. Queens is the first medical center to utilize two blood volume analyzers.Dr. Mihae Yu, Professor of Surgery and Program Director of Surgical Critical Care, said that, "I have found blood volume measurements to be extremely useful in guiding both fluid and red cell replacement. Approximately one third of the time our clinical criteria, combining physical exam, clinical information, laboratory data and chest x-ray, may be misleading in terms of the intravascular volume status. Traditional methods of guessing intravascular volume status is particularly difficult in edematous patients post shock resuscitation. Also, we may be over as well as under-transfusing blood cells when using hematocrit as a guide, since hematocrit values may not reflect red cell volume. We need to study blood volume measurements further and determine its impact on patient outcomes. However, I have found the BVA-100 to be clinically useful as to warrant a second unit."
The BVA-100 service is provided through the Nuclear Medicine Department. Queens Medical Center conducted the initial surgical critical care blood volume clinical studies, the results of which were presented at the 2005 Society of Critical Care Medicine's annual meeting. The conclusion of the study specified that knowledge about a patient's blood volume status could make a significant difference in the approach to fluid and blood management.
Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, a single use diagnostic kit. Among nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer are The Mayo Clinic, The Cleveland Clinic and New York University Medical Center. The BVA-100 measures blood volume to within a 98% accuracy. More information about the BVA-100 and other Daxor products and services can be found at www.daxor.com.
Source: Daxor
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!